Skip to Content

Metvixia FDA Approval History

FDA Approved: Yes (Discontinued) (First approved July 27, 2004)
Brand name: Metvixia
Generic name: methyl aminolevulinate hydrochloride
Dosage form: Cream
Company: Galderma Laboratories, L.P.
Treatment for: Keratosis

Marketing Status: Discontinued

Metvixia (methyl aminolevulinate hydrochloride) is a porphyrin precursor used in combination with the Aktilite CL128 lamp for treatment of actinic keratoses.

Development Timeline for Metvixia

Jun 27, 2008Approval Photocure Receives FDA Approval for Metvixia/Aktilite Photodynamic Therapy
Jul 27, 2004Approval FDA Approves Metvixia for Actinic Keratosis
Jun 17, 2004U.S. New Drug Application Approval Expected for Metvix

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.